FindTrial
Sign In

Study on different doses of additive in regional anaesthesia for post operative pain relief

A Prospective, Double Blind Randomized Control Study to assess the duration and quality of analgesia of ultrasound guided transversus abdominis plane (TAP) block with Ropivacaine and two different doses of Dexamethasone in patients with lower abdominal surgeriesâ??

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/04/018790
Enrollment
90
Registered
2019-04-25
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N719- Inflammatory disease of uterus, unspecified

Interventions

Intervention1: TAP Block: Ultrasound guided Transversus Abdominis Plane Block Control Intervention1: Dexamethasone as adjuvant to Ropivacaine: different doses of Dexamethasone as adjuvant to Ropivacai

Sponsors

AIIMS RAIPUR
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Patients willing to participate in the study and providing informed consent. 2)Age â?? >18 to 3)ASA - I and II 4)Surgery â?? lower abdominal surgeries

Exclusion criteria

Exclusion criteria: 1)Refusal to consent. 2)Allergy to local anaesthetics. 3)Skin Infection at the site of block. 4)BMI >30. 5)Pre-existing neuropathy involving lower limb. 6)Inability to comprehend VAS pain assessment score. 7)ASA III and ASA IV

Design outcomes

Primary

MeasureTime frame
comparison of pain control in TAP block with ropivacaine alone and ropivacaine with 2 doses of dexamethasone.Timepoint: comparison of pain control in TAP block with ropivacaine alone and ropivacaine with 2 doses of dexamethasone.—

Secondary

MeasureTime frame
NATimepoint: NA—

Countries

India

Contacts

Public ContactRASHMI DUBEY

AIIMS Raipur

drrashmi1993@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026